2-amino-3-((tetrahydrofuran-2-yl)methyl)quinazolin-4(3H)-one | 928707-68-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二氮杂萘
• 英文名称: 2-amino-3-((tetrahydrofuran-2-yl)methyl)quinazolin-4(3H)-one
• 英文别名: 2-amino-3-(tetrahydrofuran-2-ylmethyl)quinazolin-4(3H)-one；2-amino-3-(oxolan-2-ylmethyl)quinazolin-4-one
• CAS: 928707-68-0
• 化学式: C₁₃H₁₅N₃O₂
• 分子量: 245.281
• InChiKey: SEZMCAGTLCFNGS-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.7
• 重原子数：
  18
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.38
• 拓扑面积：
  67.9
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  2-氨基-n-(四氢呋喃-2-甲基)苯甲酰胺 、 N-氰基-4-甲基-N-苯基苯磺酰胺 在 lithium hexamethyldisilazane 作用下， 以 1,4-二氧六环 为溶剂， 生成 2-amino-3-((tetrahydrofuran-2-yl)methyl)quinazolin-4(3H)-one
  参考文献：
  名称：

  通过MCR策略有效地一锅合成2-氨基喹唑啉-4（3 H）-一衍生物

  摘要：

  开发了一种新颖的多组分反应策略，用于构造重要的结构单元，由异酸酐和胺与亲电子氰化化合物，N-氰基-4-甲基-N-苯基苯磺酰胺（NCTS）合成的2-氨基3-取代的喹唑啉酮衍生物。喹唑啉酮的合成是通过一系列连续的反应进行的，例如胺基对等酸酐的羰基的亲核攻击，然后开环和随后的脱羧，胺对腈的亲核攻击，然后杂环化。

  DOI：

  10.1016/j.tetlet.2015.08.040

文献信息

• TREATING PROTEIN FOLDING DISORDERS WITH SMALL MOLECULE CFTR CORRECTORS
  申请人：Schwiebert Erik M.

  公开号：US20140073632A1

  公开（公告）日：2014-03-13

  Novel CFTR corrector compounds that are effective in rescuing halide efflux in a cell are provided. Also provided are methods for treating protein folding disorders (e.g., cystic fibrosis). The methods include administering a CFTR corrector compound or pharmaceutically acceptable salt or prodrug thereof. Methods of screening for CFTR corrector compounds are also described herein. The methods of screening include contacting a cell that endogenously expresses a CFTR mutation with the compound to be screened and detecting a rescue of halide efflux from the cell.
• US9221840B2
  申请人：——

  公开号：US9221840B2

  公开（公告）日：2015-12-29
• [EN] TREATING PROTEIN FOLDING DISORDERS WITH SMALL MOLECULE CFTR CORRECTORS<br/>[FR] TRAITEMENT DES TROUBLES LIÉS AU REPLIEMENT DES PROTÉINES AVEC DES CORRECTEURS DE CFTR À PETITE MOLÉCULE
  申请人：DISCOVERYBIOMED INC

  公开号：WO2012158913A2

  公开（公告）日：2012-11-22

  Novel CFTR corrector compounds that are effective in rescuing halide efflux in a cell are provided. Also provided are methods for treating protein folding disorders (e.g., cystic fibrosis). The methods include administering a CFTR corrector compound or pharmaceutically acceptable salt or prodrug thereof. Methods of screening for CFTR corrector compounds are also described herein. The methods of screening include contacting a cell that endogenously expresses a CFTR mutation with the compound to be screened and detecting a rescue of halide efflux from the cell.
• An efficient one pot synthesis of 2-amino quinazolin-4(3 H )-one derivative via MCR strategy
  作者：V. Narayana Murthy、Satish P. Nikumbh、S. Praveen Kumar、L. Vaikunta Rao、Akula Raghunadh

  DOI：10.1016/j.tetlet.2015.08.040

  日期：2015.10

  multi-component reaction strategy was developed for the construction of important building blocks, 2-amino 3-substituted quinazolinone derivatives from isatoic anhydride and amine with electrophilic cyanating compound, N-cyano-4-methyl-N-phenylbenzenesulfonamide (NCTS). The quinazolinone synthesis proceeds via a sequential series of reactions such as nucleophilic attack of the amine group on the carbonyl group

  开发了一种新颖的多组分反应策略，用于构造重要的结构单元，由异酸酐和胺与亲电子氰化化合物，N-氰基-4-甲基-N-苯基苯磺酰胺（NCTS）合成的2-氨基3-取代的喹唑啉酮衍生物。喹唑啉酮的合成是通过一系列连续的反应进行的，例如胺基对等酸酐的羰基的亲核攻击，然后开环和随后的脱羧，胺对腈的亲核攻击，然后杂环化。